News & Views

Member Dues Will Remain Level in 2019

Discussion of ONS’s financial health was a key item on the agenda for the July 2018 Board of Directors meeting. As one of the quarterly face-to-face meetings the Board holds in conjunction with ONS Leadership Weekend, the meeting also provided the opportunity for in-depth discussion around several additional topics.

September 13, 2018

Trending Topics

View All Topics

FDA Approves Moxetumomab Pasudotox-tdfk for Hairy Cell Leukemia

U.S. Food and Drug Administration (FDA)

FDA Approves Moxetumomab Pasudotox-tdfk for Hairy Cell Leukemia

September 13, 2018

Evidence Is Building for Acupuncture as an Opioid Alternative for Cancer Pain

Complementary therapy

Evidence Is Building for Acupuncture as an Opioid Alternative for Cancer Pain

September 12, 2018

“It Prevents Cancer” May Be Key to HPV Vaccine Communication

Cancer prevention

“It Prevents Cancer” May Be Key to HPV Vaccine Communication

September 12, 2018

How Inhaled Cannabis May Contribute to Pulmonary Toxicity in Patients With Cancer

Clinical practice

How Inhaled Cannabis May Contribute to Pulmonary Toxicity in Patients With Cancer

September 11, 2018

What the Research Says About Supporting Cancer Survivors in Non-Oncology Settings

Oncology nurse researcher

What the Research Says About Supporting Cancer Survivors in Non-Oncology Settings

September 06, 2018

What Do You Stand For?

Incivility in nursing

What Do You Stand For?

September 05, 2018

How Are You Supporting Survivors Through EMR-Integrated Survivorship Care Plans?

Survivorship care plans

How Are You Supporting Survivors Through EMR-Integrated Survivorship Care Plans?

September 04, 2018

Caring for Patients Through All Levels of Survivorship

Caring for Patients Through All Levels of Survivorship

September 04, 2018

Longstanding NINR Director Retires After Two Decades of Developing Nursing Science

Longstanding NINR Director Retires After Two Decades of Developing Nursing Science

August 31, 2018

What Does the “E” Mean in the National Cancer Institute’s “ABCDE” Tool for Recognizing Melanoma?

What Does the “E” Mean in the National Cancer Institute’s “ABCDE” Tool for Recognizing Melanoma?

August 31, 2018

HPV Test May Be Better Than Pap Test for Women Older Than 30

Cancer screening

HPV Test May Be Better Than Pap Test for Women Older Than 30

August 30, 2018

McCain Announcement Sheds Light on Nurses’ Role in Advance Care Planning

Advance care planning

McCain Announcement Sheds Light on Nurses’ Role in Advance Care Planning

August 24, 2018

Nurse empowerment

First Large-Scale Survey of Advanced Practice Providers in Oncology Shows Growing Role for Nurse Practitioners and Physician Assistants

August 22, 2018

Recommended Surveillance Periods May Be Incorrect for Gynecologic Cancers

Recommended Surveillance Periods May Be Incorrect for Gynecologic Cancers

August 22, 2018

Use the Evidence to Support Physical Activity During and After Cancer Treatment

Nursing evidence-based practice

Use the Evidence to Support Physical Activity During and After Cancer Treatment

August 21, 2018

FDA Grants Approval for Pembrolizumab in Combination with Chemotherapy for First-line Treatment of Metastatic Nonsquamous NSCLC

U.S. Food and Drug Administration (FDA)

FDA Grants Approval for Pembrolizumab in Combination With Chemotherapy for First-Line Treatment of Metastatic Nonsquamous NSCLC

August 20, 2018

Care Coordination Standardizes Monitoring for Patients Prescribed Oral Cancer Agents

Care Coordination Standardizes Monitoring for Patients Prescribed Oral Cancer Agents

August 20, 2018

FDA Grants Nivolumab Accelerated Approval for Third-line Treatment of Metastatic SCLC

U.S. Food and Drug Administration (FDA)

FDA Grants Nivolumab Accelerated Approval for Third-Line Treatment of Metastatic SCLC

August 20, 2018

FDA Approves Lenvatinib for Unresectable Hepatocellular Carcinoma

U.S. Food and Drug Administration (FDA)

FDA Approves Lenvatinib for Unresectable Hepatocellular Carcinoma

August 16, 2018

How APRNs Can Support Patients During Oral Agent Treatment

Advanced practice nursing (APN)

How APRNs Can Support Patients During Oral Agent Treatment

August 16, 2018

Nurse empowerment

Oncology QCDR Ensures Providers Meet Merit-Based Reporting for CMS

August 15, 2018

Study Finds Association Between Increased BMI and Lower Breast Cancer Risk in Young Women

Study Finds Association Between Increased BMI and Lower Breast Cancer Risk in Young Women

August 15, 2018

Congress, Board Goals, and More Are Key Discussions During June Board Meeting

Congress, Board Goals, and More Are Key Discussions During June Board Meeting

August 14, 2018

An Oncology Nurse’s Guide to Targeted Therapy

Targeted therapy

An Oncology Nurse’s Guide to Targeted Therapy

August 14, 2018

Which of the Following Isn’t a Breast Cancer Surveillance Recommendation?

Clinical practice

Which of the Following Isn’t a Breast Cancer Surveillance Recommendation?

August 09, 2018

TNM Gets an Upgrade in Eighth Edition Staging Guidelines

Clinical practice guidelines

TNM Gets an Upgrade in Eighth Edition Staging Guidelines

August 09, 2018

FDA Approves Mogamulizumab-kpkc for Mycosis Fungoides or Sézary Syndrome

U.S. Food and Drug Administration (FDA)

FDA Approves Mogamulizumab-kpkc for Mycosis Fungoides or Sézary Syndrome

August 08, 2018

Men May Have Greater Survival Benefit From Immune Checkpoint Inhibitors

Men May Have Greater Survival Benefit From Immune Checkpoint Inhibitors

August 08, 2018

Updated Core Competencies Reflect Evolution of Nurse Navigator Role

Nurse navigator

Updated Core Competencies Reflect Evolution of Nurse Navigator Role

August 07, 2018

Remembering ONS Member Meneses’ Contributions to Oncology Nursing

Meneses Left Legacy of Contributions to Cancer Survivorship and Quality of Life

August 06, 2018

Oncology Nursing’s Future—Preparing the Next ONS Strategic Plan

Oncology Nursing’s Future—Preparing the Next ONS Strategic Plan

August 02, 2018

Using CTCAE to Report Immunotherapy Adverse Events

Using CTCAE to Report Immunotherapy Adverse Events

August 01, 2018

Annual Cancer Report Shows New Trends in Prostate Cancer

Prostate cancer

Annual Cancer Report Shows New Trends in Prostate Cancer

August 01, 2018

How Is CTCAE Improving Research and Patient Care?

Oncology clinical trials

How Is CTCAE Improving Research and Patient Care?

August 01, 2018

FDA Approves Lusutrombopag for Thrombocytopenia in Adults With Chronic Liver Disease

U.S. Food and Drug Administration (FDA)

FDA Approves Lusutrombopag for Thrombocytopenia in Adults With Chronic Liver Disease

FDA Approves Jobenguane I 131 for Rare Adrenal Gland Tumors

U.S. Food and Drug Administration (FDA)

FDA Approves Jobenguane I 131 for Rare Adrenal Gland Tumors

drug spill safe handling

Which of the Following Drug Spills Doesn’t Require a Full-Facepiece, Chemical Cartridge-Type Respirator or PAPR?

The Oncology Nurse Experience in Managing Adverse Events in Patients Receiving Ibrutinib

The Oncology Nurse Experience in Managing Adverse Events in Patients Receiving Ibrutinib

APRNs Must Stay Educated About Medical Cannabis in Cancer Care

Advanced practice nursing (APN)

APRNs Must Stay Educated About Medical Cannabis in Cancer Care

AHRQ Shutters National Guideline Clearinghouse Because of Budget Cuts

Evidence-based care

AHRQ Shutters National Guideline Clearinghouse Because of Budget Cuts

Evidence-Based Practice Helps Standardize Care After Pancreatic Cancer Surgery

Nursing evidence-based practice

Evidence-Based Practice Helps Standardize Care After Pancreatic Cancer Surgery

$FDA Approves Ivosidenib for Relapsed or Refractory AML$

U.S. Food and Drug Administration (FDA)

FDA Approves Ivosidenib for Relapsed or Refractory AML

Nurse empowerment

ONS Publications, Podcast Receive Industry Honors

Nurse empowerment

The American Academy of Nursing Inducts Seven ONS Members as 2017 Fellows

What Happens if Patients With Cancer Have Bedbugs?

What Happens if Patients With Cancer Have Bedbugs?

Nurse empowerment

The American Academy of Nursing Inducts 16 ONS Members as 2018 Fellows

FDA Expands Ribociclib Indication in HR-Positive, HER2-Negative Advanced, Metastatic Breast Cancer

U.S. Food and Drug Administration (FDA)

FDA Expands Ribociclib Indication in HR-Positive, HER2-Negative Advanced, Metastatic Breast Cancer

Is Palliative Care the Answer to the Medical Aid in Dying Discussion?

Palliative care

Is Palliative Care the Answer to the Medical Aid in Dying Discussion?

Patient on a Clinical Trial Needs to Visit the Dentist

Oncology clinical trials

What Would You Say if Your Patient on a Clinical Trial Needs to Visit the Dentist?

Back to Top ▲